Insulet Corp reports results for the quarter ended June 30 - Earnings Summary

• Insulet Corp PODD.OQ reported quarterly adjusted earnings of 32 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 55 cents. The mean expectation of twenty three analysts for the quarter was for earnings of 93 cents per share. Wall Street expected results to range from 78 cents to $1.13 per share.

• Revenue rose 32.9% to $649.10 million from a year ago; analysts expected $612.22 million.

• Insulet Corp's reported EPS for the quarter was 32 cents​.

• The company reported quarterly net income of $22.5 million.

• Insulet Corp shares had fallen by 11.7% this quarter and gained 6.2% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 1.1% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 22 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

• Wall Street's median 12-month price target for Insulet Corp is $334.00, about 17% above its last closing price of $277.30

This summary was machine generated from LSEG data August 7 at 04:27 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)